eft ventricular (LV) dysfunction is a common complication of uremia, 1 but its cause is unknown. Some reports [2] [3] [4] [5] [6] have suggested that parathyroid hormone (PTH), a uremic toxin, may be a depressant factor on cardiac function. We present a case of LV dysfunction in a hemodialysis patient with secondary hyperparathyroidism who revealed marked improvement of LV function after parathyroidectomy.
Case Report
A 52-year-old woman was admitted to hospital because of exertional dyspnea. She had been hemodialyzed for advanced renal failure as a result of chronic glomerulonephritis since she was 40 years old. She was diagnosed as having hypothyroidism associated with Hashimoto's disease and thyroid hormone had been administered. The hemodialysis had been performed for 4 h, 3 times a week and dry weight was 37.5 kg. Over the past 6 months, she had developed gradually worsening dyspnea.
On physical examination, her height and weight were 155 cm and 38 kg, body temperature was 36.5°C, pulse rate was 74 beats/min, and blood pressure was 114/74 mmHg. On auscultation, pansystolic murmur (Levine 2/6) was audible at the apex. Her lungs were clear. No neurological abnormalities were detected. The chest X-ray on admission showed a marked increase of the cardiothoracic ratio (CTR) (Fig 1A) . The CTR increased up to 62% from 53% a year earlier. The electrocardiogram (ECG) showed left axis deviation, poor R wave progression in leads V1-4, and S-T segment depression with T-wave inversion in leads I, II, aVL, V5 and V6, and those were in accordance with LV hypertrophy (Fig 2) . Laboratory tests 1 day after hemodialysis showed high levels of blood urea nitrogen (BUN), creatinine, calcium (Ca), phosphorus (P), alkaline phosphatase (ALP), and intact PTH, which were caused by advanced renal failure and secondary hyperparathyroidism. C-reactive protein (CRP) and erythrocyte sedimentation rate (ESR) were slightly increased. There was mild anemia. Free tri-iodothyronine (T3), free thyroxine (T4), and thyroid-stimulating hormone (TSH) levels were within normal limits (Table 1) . Transthoracic echocardiography 1 day after hemodialysis showed LV dilatation and reduced contraction. No regional LV wall motion abnormality was detected (Fig 3A) .
In order to investigate the etiology of reduced LV contraction, cardiac catheterization was performed before hemodialysis on the seventh day of hospitalization. Coronary angiography showed no fixed stenosis. Left ventricu- A 52-year-old woman, a hemodialysis patient, was admitted because of exertional dyspnea. Echocardiography showed left ventricular (LV) dilatation and reduced contraction. Coronary angiography showed no fixed stenosis. She had elevated levels of parathyroid hormone (PTH) as a result of secondary hyperparathyroidism with advanced renal failure. After parathyroidectomy, marked improvement of LV function following immediate decrease of blood levels of PTH was observed. It is suggested that PTH might have a significant role in the pathogenesis of LV dysfunction and that parathyroidectomy might be effective as a therapy for heart failure in some patients with secondary hyperparathyroidism and LV dysfunction. lography showed LV dilatation (end-diastolic volume 266 ml, end-systolic volume 215 ml), decreased LV ejection fraction (19%), and mild mitral regurgitation. Hemodynamic data revealed high pulmonary capillary wedge pressure and pulmonary artery pressure that was compatible with left heart failure ( Table 2) . Initially, LV dysfunction seemed to be the result of inappropriate management of hemodialysis. Thus, dry weight was reduced to 35.5 kg and low-dose digoxin was administered. Although CTR decreased after management, echocardiographic parameters did not improve, and orthostatic hypotension and hypotension during hemodialysis developed. Subsequently, it was thought that secondary hyperparathyroidism might be an alternative cause of LV dysfunction. After written informed consent was obtained, parathyroidectomy was performed followed by Ca supplementation. After parathyroidectomy, blood levels of PTH decreased immediately, echocardiographic parameters improved (Table 3 , Fig 3B) , and the CTR decreased to 51% (Fig 1B) . Also, the patient's symptoms improved gradually and hypotension did not occur after surgery. She was discharged on the 69th day of hospitalization.
Discussion

Effect of Parathyroid Hormone as a Depressant Factor on Cardiac Function
LV dysfunction is a common complication of uremia, 1 but its cause is unknown. Patients with advanced renal fail- ure often have secondary hyperparathyroidism and markedly elevated blood levels of PTH. 7, 8 Several experimental studies have shown that PTH affects cardiac function. PTH increases the heart's beating rate 9 and produces positive inotropic effects 10, 11 by augmenting calcium entry into heart cells, and causes disturbance of myocardial energy metabolism following calcium overload. [3] [4] [5] A clinical study has also suggested possible roles played by PTH on cardiac dysfunction. Drueke et al have shown an improvement in LV function shortly after parathyroidectomy in hemodialysis patients with secondary hyperparathyroidism. 2 Recently, it has been shown that PTH affects not only cardiomyocytes, but also cardiac fibroblasts, playing an important role in the genesis of cardiac fibrosis in uremia. 6 Conversely, Gafter et al have reported that parathyroidectomy has little effect on long-term cardiac performance in hemodialysis patients with normal cardiac function. 12 London and colleagues also did not establish a cause -effect relationship between myocardial abnormalities and the severity of hyperparathyroidism. 13 Huting et al have found that LV hypertrophy and parameters of systolic function are unrelated to secondary hyperparathyroidism in hemodialysis patients. 14 
Clinical Significance of Parathyroid Hormone
It is unclear in the present case when LV dysfunction and elevation of PTH levels occurred. Marked improvement of LV dilatation and reduced contraction after parathyroidectomy make it unlikely that LV dysfunction was due to primary cardiomyopathy and irreversible secondary cardiomyopathy. Also, it is difficult to consider that LV dysfunction resulted only from the inappropriate management of hemodialysis because LV contraction did not improve by strict control of dry weight after admission. Although myocarditis might be another cause of LV dysfunction, there was neither a significant elevation of cardiac enzyme nor ECG changes throughout the clinical course. In the present case, marked improvement of LV function following an immediate decrease of PTH levels after parathyroidectomy and the lack of evidence for myocarditis make it likely that PTH played a significant role in the pathogenesis of LV dysfunction.
In some points, the present case was different from the 2 clinical studies 2,12 mentioned previously, which evaluated the effect of parathyroidectomy on LV function. First, LV function of the patient in the present case was remarkably poor compared with that of the patients in the other 2 studies. Gafter and colleagues have demonstrated that parathyroidectomy had little effect on cardiac performance in patients with normal LV contraction. 12 None of patients in the study by Drueke et al showed any clinical evidence of heart failure, although some of them had reduced LV contraction 2 . Second, in the present case, an improvement of both LV systolic and diastolic function was observed after parathyroidectomy. Finally, in the present case, various clinical presentations improved after parathyroidectomy; not only did the chest X-ray findings and echocardiographic parameters improve, but also any symptoms and hypotension were dissolved. The clinical course in this particular case suggested that parathyroidectomy might be effective as a therapy for heart failure in some patients with secondary hyperparathyroidism and LV dysfunction.
Conclusion
We present a case of LV dysfunction in a hemodialysis patient with secondary hyperparathyroidism. Marked improvement of LV function following an immediate decrease of blood levels of PTH after parathyroidectomy was evident, suggesting that PTH might play a significant role in the pathogenesis of LV dysfunction. Parathyroidectomy might be effective as a therapy for heart failure in some patients with secondary hyperparathyroidism and LV dysfunction. 
